SCHEMBL5170218

SCHEMBL5170218

CC(C)CC1CN(C(=O)O)CCc2cc(Cc3cnc(NC(=O)CCCBr)cn3)ccc21

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DEGS1 O15121 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5183100 0.89 ACACB (0.32) —
SCHEMBL5170212 0.87 BDKRB1 (0.30) —
SCHEMBL5170769 0.83 SLC18A2 (0.33) —
SCHEMBL5171053 0.82 HRH3 (0.35) —
SCHEMBL5183241 0.81 HRH3 (0.33) —
SCHEMBL5170766 0.81 SMO (0.34) —
SCHEMBL5170245 0.80 HRH3 (0.35) —
SCHEMBL5173434 0.80 KDM4C (0.35) —
SCHEMBL5169168 0.78 PRMT5 (0.37) —
SCHEMBL5170526 0.78 KCNH2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778643-A1 TETRAHYDROBENZAZEPINES AS ANTAGONISTS AND/OR REVERSE AGONISTS OF THE HISTAMINE H3 RECEPTOR GLAXO GROUP LIMITED (GB) 2007-05-02 — — EP disclosed
WO-2006018260-A1 TETRAHYDROBENZAZEPINES AS ANTAGONISTS AND/OR REVERSE AGONISTS OF THE HISTAMINE H 3 RECEPTOR GLAXO GROUP LIMITED (GB) 2006-02-23 — — WO disclosed
Send feedback